Literature DB >> 4289551

ACTH antibodies in patients receiving depot porcine ACTH to hasten recovery from pituitary-adrenal suppression.

N Fleischer, K Abe, G W Liddle, D N Orth, W E Nicholson.   

Abstract

Six patients who had experienced prolonged steroid-induced pituitary-adrenal suppression were treated with 100 U of depot procine ACTH every 2 to 4 days for several months. Such treatment did not hasten the recovery of normal pituitary-adrenal function compared with the rate of recovery of a group of similarly suppressed patients who received no depot ACTH. Eight of nine patients who received prolonged courses of depot porcine ACTH developed antibodies to ACTH that cross-reacted with endogenous ACTH, binding it in the circulation in inactive form and retarding its removal from the circulation. The presence of such antibodies did not in itself grossly alter pituitary-adrenal interrelationships.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4289551      PMCID: PMC297038          DOI: 10.1172/JCI105522

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  RADIOIMMUNOASSAY OF HUMAN PLASMA ACTH.

Authors:  R S YALOW; S M GLICK; J ROTH; S A BERSON
Journal:  J Clin Endocrinol Metab       Date:  1964-11       Impact factor: 5.958

2.  PERSISTENCE OF DIURNAL RHYTHMICITY IN PLASMA ACTH CONCENTRATIONS IN CORTISOL-DEFICIENT PATIENTS.

Authors:  A L GRABER; J R GIVENS; W E NICHOLSON; D P ISLAND; G W LIDDLE
Journal:  J Clin Endocrinol Metab       Date:  1965-06       Impact factor: 5.958

3.  A METHOD FOR SEPARATING SMALL QUANTITIES OF MSH AND ACTH WITH GOOD RECOVERY OF EACH.

Authors:  D P ISLAND; N SHIMIZU; W E NICHOLSON; K ABE; E OGATA; G W LIDDLE
Journal:  J Clin Endocrinol Metab       Date:  1965-07       Impact factor: 5.958

4.  Complications in the management of Cushing's syndrome, including anaphylactic reaction to intravenous adrenocorticotropin after subtotal adrenalectomy.

Authors:  G T PERKOFF; B V JAGER; F H TYLER
Journal:  J Clin Endocrinol Metab       Date:  1955-03       Impact factor: 5.958

5.  Immunologic aspects of insulin.

Authors:  R S YALOW; S A BERSON
Journal:  Am J Med       Date:  1961-12       Impact factor: 4.965

6.  The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

Authors:  R H SILBER; C C PORTER
Journal:  J Biol Chem       Date:  1954-10       Impact factor: 5.157

7.  On the structure of human corticotropin (adrenocorticotropic hormone).

Authors:  T H LEE; A B LERNER; V BUETTNER-JANUSCH
Journal:  J Biol Chem       Date:  1961-11       Impact factor: 5.157

8.  A sensitive biologic assay for ACTH.

Authors:  H S LIPSCOMB; D H NELSON
Journal:  Endocrinology       Date:  1962-07       Impact factor: 4.736

9.  Studies of ACTH antibodies and their reactions with inactive analogues of ACTH.

Authors:  N Fleischer; J R Givens; K Abe; W E Nicholson; G W Liddle
Journal:  Endocrinology       Date:  1966-05       Impact factor: 4.736

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

View more
  12 in total

1.  Newer trends in corticosteroid therapy.

Authors:  L N Meleyco
Journal:  Calif Med       Date:  1970-06

Review 2.  Corticosteroids: clinical pharmacology and therapeutic use.

Authors:  S L Swartz; R G Dluhy
Journal:  Drugs       Date:  1978-09       Impact factor: 9.546

3.  Development of antibodies during long-term therapy with corticotrophin in rheumatoid arthritis. I. Porcine ACTH.

Authors:  D Glass; J R Daly
Journal:  Ann Rheum Dis       Date:  1971-11       Impact factor: 19.103

4.  Development of antibodies during long-term therapy with corticotrophin in rheumatoid arthritis. II. Zinc tetracosactrin (Depot Synacthen).

Authors:  D Glass; G Nuki; J R Daly
Journal:  Ann Rheum Dis       Date:  1971-11       Impact factor: 19.103

5.  Corticosteroids and hypothalamic-pituitary-adrenocortical function.

Authors: 
Journal:  Br Med J       Date:  1980-03-22

Review 6.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

7.  Acquired Resistance to Corticotropin Therapy in Nephrotic Syndrome: Role of De Novo Neutralizing Antibody.

Authors:  Pei Wang; Yan Zhang; Yu Wang; Andrew S Brem; Zhangsuo Liu; Rujun Gong
Journal:  Pediatrics       Date:  2017-07       Impact factor: 7.124

8.  An evaluation of antibodies and clinical resistance to salmon calcitonin.

Authors:  F R Singer; J P Aldred; R M Neer; S M Krane; J T Potts; K J Bloch
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

9.  The nature of the immunoreactive lipotropins in human plasma and tissue extracts.

Authors:  K Tanaka; W E Nicholson; D N Orth
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  Relapse of Nephrotic Syndrome after Adrenocorticotropic Hormone-Induced Remission: Implications of Adrenocorticotropic Hormone Antibodies.

Authors:  Snehal Shrivastava; Bohan Chen; Lance D Dworkin; Deepak K Malhotra; Rujun Gong
Journal:  Am J Nephrol       Date:  2020-03-18       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.